Phase IIa, 90-Day Safety, Adherence, and Acceptability Study of Intravaginal Rings Releasing Tenofovir With and Without Levonorgestrel Among Women in Western Kenya
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Aug 2019
Price : $35 *
At a glance
- Drugs Levonorgestrel (Primary) ; Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 06 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 25 Jul 2019 Planned End Date changed from 1 Jun 2019 to 1 Aug 2019.
- 25 Jul 2019 Planned primary completion date changed from 1 May 2019 to 1 Aug 2019.